PF-Atlas › Clinical Trials › NCT03020719
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Oral Glutathione · Phase 2
Registry ID
NCT03020719
Phase
Phase 2
Status
Completed
Drug / intervention
Oral Glutathione
Sponsor
University of Minnesota
Start
2017-06-14
About this trial
Oral Glutathione is evaluated in NCT03020719, a Phase 2 idiopathic pulmonary fibrosis study sponsored by University of Minnesota. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03020719 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.